Key result
Higher atherogenic index of plasma predicts ~218% greater slow/no-reflow risk after emergency PCI.
Why the study?
Does the atherogenic index of plasma (AIP) predict the occurrence of slow flow/no-reflow in patients with acute myocardial infarction undergoing emergency PCI?
Cohort (n=964)
No
Does the atherogenic index of plasma (AIP) predict the occurrence of slow flow/no-reflow in patients with acute myocardial infarction undergoing emergency PCI?
Answers are grounded in this paper and cite their sources.
AIP may aid SF/NR risk stratification after emergency PCI in AMI; hypothesis-generating and should not yet change practice.
Background Percutaneous coronary intervention (PCI) is the primary reperfusion strategy for acute myocardial infarction (AMI); however, some patients develop slow flow/no‐reflow (SF/NR) after the procedure, which adversely affects prognosis. Atherogenic index of plasma (AIP) is a reliable biomarker of cardiovascular risk, yet its predictive value for SF/NR following emergency PCI in AMI patients remains unclear. Objective This study aimed to investigate the association between AIP and the occurrence of SF/NR in AMI patients undergoing emergency PCI. Methods A retrospective analysis was conducted on 964 patients initially diagnosed with AMI who underwent PCI. The participants were categorized into SF/NR ( n = 251) and normal flow ( n = 713) groups on the basis of TIMI flow grade. Statistical analyses including LASSO regression, multivariate logistic regression, ROC curve analysis, RCS regression, subgroup analysis, and the development of a nomogram model were performed. Results AIP was identified as an independent risk factor for postoperative SF/NR (OR = 3.184, p < 0.05). The AUC for AIP in the prediction of SF/NR was 0.737. Higher AIP quartiles were associated with increased risk, and a nonlinear relationship was observed. The constructed nomogram model demonstrated good predictive performance (AUC = 0.745), satisfactory calibration in internal validation, and favorable clinical utility. Subgroup analysis confirmed the consistent predictive ability of AIP across different strata. Conclusion AIP may be associated with the risk of SF/NR after emergency PCI in AMI patients. Combined with white blood cell count and triglyceride levels, AIP could potentially assist in early identification of high‐risk individuals, which warrants further validation in prospective studies. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2500108501
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) conducted a cohort in Acute Myocardial Infarction (AMI) (n=964). Atherogenic Index of Plasma (AIP) vs. Lower AIP levels was evaluated on Occurrence of slow flow/no-reflow (SF/NR) after emergency PCI (OR 3.184, 95% CI 2.162-4.689, p=<0.001). The atherogenic index of plasma was identified as an independent risk factor for slow flow/no-reflow after emergency percutaneous coronary intervention in patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: